Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1111/bjh.16874

Type

Journal article

Journal

Br J Haematol

Publication Date

07/2020

Volume

190

Pages

e83 - e86

Keywords

COVID-19, multiple myeloma, systemic antic-cancer therapy, Adult, Aged, Antineoplastic Agents, Betacoronavirus, COVID-19, Clinical Audit, Coronavirus Infections, Female, Humans, Male, Middle Aged, Multiple Myeloma, Pandemics, Pneumonia, Viral, Recurrence, SARS-CoV-2, United Kingdom